Pharma News

AZ-3102 by Azafaros for Sandhoff Disease (Jatzkewitz-Pilz Syndrome): Likelihood of Approval

AZ-3102 is under clinical development by Azafaros and currently in Phase I for Sandhoff Disease (Jatzkewitz-Pilz Syndrome).

Source link
#AZ3102 #Azafaros #Sandhoff #Disease #JatzkewitzPilz #Syndrome #Likelihood #Approval

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *